Hui-Ping Tsai

ORCID

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Venues

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy 68 (4) (2024)
Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy 68 (4) (2024)
Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy (2024)
Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy 68 (4) (2024)
Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy 68 (4) (2024)
Wen-Fang Tang, Yu-Hsiu Chang, Cheng-Chin Lin, Jia-Rong Jheng, Chung-Fan Hsieh, Yuan-Fan Chin, Tein-Yao Chang, Jin-Ching Lee, Po-Huang Liang, Chia-Yi Lin, Guan-Hua Lin, Jie-Yun Cai, Yu-Li Chen, Yuan-Siao Chen, Shan-Ko Tsai, Ping-Cheng Liu, Chuen-Mi Yang, Tolou Shadbahr, Jing Tang, Yu-Lin Hsu, Chih-Heng Huang, Ling-Yu Wang, Cheng Cheung Chen, Jyh-Hwa Kau, Yi-Jen Hung, Hsin-Yi Lee, Wen-Chieh Wang, Hui-Ping Tsai, Jim-Tong Horng
BPR3P0128, a non-nucleoside RNA-dependent RNA polymerase inhibitor, inhibits SARS-CoV-2 variants of concern and exerts synergistic antiviral activity in combination with remdesivir. Antimicrobial agents and chemotherapy 68 (4) (2024)

Hui-Ping Tsai.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hui-Ping Tsai